Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis
1998

Tie2/Tek as a Marker for Breast Tumor Angiogenesis

Sample size: 143 publication Evidence: moderate

Author Information

Author(s): KG Peters, A Coogan, D Berry, J Marks, JD Iglehart, CD Kontos, P Rao, S Sankar, E Trogan

Primary Institution: Duke University Medical Center

Hypothesis

Does the expression of Tie2/Tek in breast tumor vasculature serve as a marker for evaluating tumor angiogenesis?

Conclusion

The study found that Tie2 expression is significantly higher in breast tumors compared to normal and benign breast tissues, suggesting its potential as a marker for tumor vasculature.

Supporting Evidence

  • Tie2 expression was detected in the endothelium of all breast tissues examined.
  • The strongest expression of Tie2 was seen in vascular hotspots within the inflammatory infiltrate at the periphery of invasive tumors.
  • The proportion of Tie2-positive vessels was significantly higher in breast tumors than in normal breast tissue or benign breast lesions.

Takeaway

This study looked at a special protein called Tie2 in breast cancer and found that it shows up more in tumors than in normal tissue, which could help doctors understand how tumors grow.

Methodology

Immunohistochemistry was used to evaluate Tie2 expression in normal breast tissue, benign lesions, and breast tumors.

Limitations

No significant correlation was found between Tie2 expression and clinical prognostic indicators such as tumor size or lymph node status.

Participant Demographics

Included 10 normal breast specimens, 10 benign lesions, and 123 breast tumors, primarily invasive ductal carcinomas.

Statistical Information

P-Value

0.0001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication